Israeli drug maker Teva opens new EUR 11.3mn plant in Hungary.

By bne IntelliNews April 26, 2010
Israeli pharmaceutical company Teva launched commercial operations of its new plant in the Hungarian city of Debrecen , director of the company's local unit, Lajos Hegedus, announced. It already had an established base at the city and the new facility would expand its tablets production capacity in the country by 20% to 12bn tablets annually. Hegedus added that Teva planned further investments in its Hungarian base, targeting to build total production capacity of 20bn tablets per year. The new plant would open up 50-60 new job positions and also provide opportunities for R&D activities. Total investment costs for its construction are estimated at HUF 3bn (EUR 11.3mn) with 15.3% of the project costs coming from the EU funds and cofinancing from the national budget.

Related Articles

Assets of Hungarys investment funds up 3.2% m/m in Feb 2013.

Hungary's investment funds had aggregate assets of HUF 3.657tn (EUR 11.98bn) as of end-February 2013, up by 3.2% m/m, MTI news agency reported citing data from the association of investment funds ... more

Hungary's number of employees down 0.6% y/y in Jan 2013.

The number of employees in Hungary's public and private sectors fell for the tenth straight month in January 2013 declining by 0.6% y/y to 2.574mn, the statistics office informed. The decline ... more

Hungarys MVM clears deal for purchasing E.ONs local units.

The assembly of state-owned Hungarian Electricity Works (MVM) has approved the purchase of the local gas business of German power utility E.ON, Hungary AM reported, citing local daily Magyar ... more

Notice: Undefined index: subject_id in /var/www/html/application/controllers/IndexController.php on line 335
Dismiss